Md. firm ’s treatment gets key FDA nod for some Covid patients with drug-resistant infections

The Maryland biotech's virus-based therapy targets superbugs.

Source: bizjournals.com Health Care:Biotechnology headlines - November 19, 2020 Category: Biotechnology Authors: Sara Gilgore Source Type: news